AstraZeneca shares drop 6% after company announces 'routine' safety pause in vaccine trialCNBC • 09/08/20
Nine biopharma CEOs pledge to make safety the main focus in coronavirus vaccine developmentCNBC • 09/08/20
Moderna, Pfizer, Johnson & Johnson, And Others To Make Pledge in Response to Coronavirus Vaccine Political PressureThe Motley Fool • 09/05/20
3 Drugmakers Most Likely to Launch Coronavirus Vaccines in the U.S. by the End of 2020The Motley Fool • 09/04/20
As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval24/7 Wall Street • 09/02/20